Latest news

Tubulis lands €308 million in record Series C to lead next-gen cancer drug race

Tubulis lands €308 million in record Series C to lead next-gen cancer drug race

Eduardo Longoria
Daily Snap - 15. October 2025

Daily Snap - 15. October 2025

Joachim Eeckhout
Kailera raises $600M to take on Eli Lilly in obesity drug race

Kailera raises $600M to take on Eli Lilly in obesity drug race

Eduardo Longoria
BioCryst bets big on rare disease with $700M Astria buyout

BioCryst bets big on rare disease with $700M Astria buyout

Eduardo Longoria
Daily Snap - 14. October 2025

Daily Snap - 14. October 2025

Joachim Eeckhout
Regeneron’s gene therapy restores hearing in children with genetic deafness

Regeneron’s gene therapy restores hearing in children with genetic deafness

Eduardo Longoria
Excellergy raises $70M to reinvent allergy treatment with multi-action drug

Excellergy raises $70M to reinvent allergy treatment with multi-action drug

Eduardo Longoria
Daily Snap - 13. October 2025

Daily Snap - 13. October 2025

Joachim Eeckhout
BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

Eduardo Longoria
Evommune files for IPO to back oral immune drugs for skin conditions

Evommune files for IPO to back oral immune drugs for skin conditions

Eduardo Longoria
Daily Snap - 10. October 2025

Daily Snap - 10. October 2025

Joachim Eeckhout
AviadoBio expands into eye diseases with $413M UgeneX deal

AviadoBio expands into eye diseases with $413M UgeneX deal

Eduardo Longoria
FirstBack
56789101112
Next Last